Saturday, June 3, 2023
SCIENMAG: Latest Science and Health News
No Result
View All Result
  • Login
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
No Result
View All Result
Scienmag - Latest science news from science magazine
No Result
View All Result
Home SCIENCE NEWS Medicine & Health

A banner year for pharma

December 5, 2018
in Medicine & Health
0
Share on FacebookShare on Twitter

As 2018 draws to a close, the pharmaceutical industry is celebrating a prosperous year of new investments and therapeutic breakthroughs. These successes were driven by cutting-edge science and progress in finally translating long-standing technology into actual products, according to a cover story in Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society.

The biotech industry benefited from a wave of investment in 2018 from venture capital firms, writes Senior Correspondent Lisa M. Jarvis. In addition, biotech initial public offerings hit a new record. Promising developments during the year include the approval of the first RNA interference drug, advancements for the gene-editing tool CRISPR and the first crop of cannabis-based therapeutics.

In August, the U.S. Food and Drug Administration (FDA) approved Alnylam Pharmaceuticals’ Onpattro, the first RNA interference therapeutic to reach the market. In development for 16 years, Onpattro treats a rare genetic disorder called hereditary transthyretin-mediated amyloidosis. Interest in other RNA therapeutics, such as antisense oligonucleotides and mRNA vaccines, is also flourishing. Meanwhile, although CRISPR has suffered recent setbacks related to possible safety issues, companies are forging ahead with clinical trials planned in 2019 for sickle cell disease, a rare genetic form of blindness and liver disorders. 2018 also witnessed the first FDA approval of a cannabis-based drug: Epidiolex, made by GW Pharmaceuticals, treats rare seizure disorders in children and young adults. Other companies are following suit with clinical development programs targeting cannabinoid receptors.

###

The article, “C&EN’s Year in Pharma 2018,” is freely available here.

The American Chemical Society, the world’s largest scientific society, is a not-for-profit organization chartered by the U.S. Congress. ACS is a global leader in providing access to chemistry-related information and research through its multiple databases, peer-reviewed journals and scientific conferences. ACS does not conduct research, but publishes and publicizes peer-reviewed scientific studies. Its main offices are in Washington, D.C., and Columbus, Ohio.

To automatically receive news releases from the American Chemical Society, contact [email protected].

Follow us on Twitter | Facebook

Media Contact
Katie Cottingham
[email protected]
301-775-8455

Tags: Biomedical/Environmental/Chemical EngineeringChemistry/Physics/Materials SciencesGene TherapyGenesGeneticsPharmaceutical ChemistryPharmaceutical SciencePharmaceutical SciencesPharmaceutical/Combinatorial Chemistry
Share25Tweet16Share4ShareSendShare
  • UTHSC Pangenome Researchers

    UTHSC researchers’ work on human pangenome aids understanding of common chromosomal abnormality

    66 shares
    Share 26 Tweet 17
  • Null results research now published by major behavioral medicine journal

    781 shares
    Share 312 Tweet 195
  • Pediatric Cancer Research Foundation announces 2023 grant recipients to accelerate discovery of new treatments for pediatric cancers

    68 shares
    Share 27 Tweet 17
  • For advanced, HER2-amplified bile duct cancers, antibody treatment trial shows promising results

    65 shares
    Share 26 Tweet 16
  • Case report: former football player’s cognitive symptoms improved after study revealed alternative diagnosis and treatment

    67 shares
    Share 27 Tweet 17
  • Multiple sclerosis more prevalent in Black Americans than previously thought

    64 shares
    Share 26 Tweet 16
ADVERTISEMENT

About us

We bring you the latest science news from best research centers and universities around the world. Check our website.

Latest NEWS

Null results research now published by major behavioral medicine journal

Element creation in the lab deepens understanding of surface explosions on neutron stars

Why expensive wine appears to taste better

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 206 other subscribers

© 2023 Scienmag- Science Magazine: Latest Science News.

No Result
View All Result
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US

© 2023 Scienmag- Science Magazine: Latest Science News.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In